The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Ma'en Obeidat1,2
- Mohsen Sadatsafavi1
- Don D Sin1,2
- 1 University of British Columbia, Vancouver, Canada
- 2 St Paul's Hospital, Vancouver, Canada
Correspondence: Don.Sin@hli.ubc.ca
Competing interests:
Don Sin has received personal fees for sitting on COPD advisory boards of Sanofi‐Aventis, AstraZeneca and Boehringer Ingelheim, and for speaking engagements from AstraZeneca and Boehringer Ingelheim, outside of the submitted work.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Summary